Incidence of lymphoceles after robot-assisted pelvic lymph node dissection

BJU International

Volumn 108, Issue 7, 2011, Pages 1185-1189

  Orvieto, Marcelo A ^a,b   Coelho, Rafael F ^b,c   Chauhan, Sanket ^b   Palmer, Kenneth J ^b   Rocco, Bernardo ^b   Patel, Vipul R ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b Global Robotic Institute at Florida Hospital   (United States)

^c HOSPITAL ISRAELITA ALBERT EINSTEIN   (Brazil)

Author keywords

lymphocele; lymphodeveatary complications; pelvic lymph node; robotics

Indexed keywords

ABDOMINAL DISTENSION; ADULT; AGED; ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; FOLLOW UP; HUMAN; ILEUS; INCIDENCE; LEG PAIN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOCELE; MAJOR CLINICAL STUDY; MALE; ORGAN SIZE; PELVIS LYMPH NODE; PREDICTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK BENEFIT ANALYSIS; RISK FACTOR; ROBOTICS; SURGICAL APPROACH; TUMOR VOLUME;

AGED; AGED, 80 AND OVER; HUMANS; INCIDENCE; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; LYMPHOCELE; MALE; MIDDLE AGED; PELVIS; PROSPECTIVE STUDIES; PROSTATIC NEOPLASMS; ROBOTICS;

EID: 80051892760     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2011.10094.x     Document Type: Article

References (21)

1. Palapattu GS, Allaf ME, Trock BJ, Epstein JI, Walsh PC,. Prostate specific antigen progression in men with lymph node metastases following radical prostatectomy: results of long-term followup. J Urol 2004; 172: 1860-4 (Pubitemid 39363074)
2. Daneshmand S, Quek ML, Stein JP, et al,. Prognosis of patients with lymph node positive prostate cancer following radical prostatectomy: long-term results. J Urol 2004; 172: 2252-5 (Pubitemid 39507502)
3. Crawford ED, Batuello JT, Snow P, et al,. The use of artificial intelligence technology to predict lymph node spread in men with clinically localized prostate carcinoma. Cancer 2000; 88: 2105-9 (Pubitemid 30233212)
4. Kawakami J, Meng MV, Sadetsky N, et al,. Changing patterns of pelvic lymphadenectomy for prostate cancer: results from CaPSURE. J Urol 2006; 176: 1382-6 (Pubitemid 44316850)
5. Ward JF, Slezak JM, Blute ML, Bergstralh EJ, Zincke H,. Radical prostatectomy for clinically advanced (cT3) prostate cancer since the advent of prostate-specific antigen testing: 15-year outcome. BJU Int 2005; 95: 751-6 (Pubitemid 40547200)
6. Bader P, Bukhard FC, Marwalder R, Studer UE,. Disease progression and survival of patients with positive lymph nodes after radical prostatectomy. Is there a chance of cure. J Urol 2003; 169: 849-54 (Pubitemid 36188105)
7. Heidenreich A, Varga Z, von Knobloch R,. Extended pelvic lymphadenectomy in patients undergoing radical prostatectomy: high incidence of lymph node metastasis. J Urol 2002; 167: 1681-6 (Pubitemid 34240702)
8. Allaf ME, Palapattu GS, Trock BJ, Carter HB, Walsh PC,. Anatomical extent of lymph node dissection: impact on men with clinically localized prostate cancer. J Urol 2004; 172: 1840-4 (Pubitemid 39363069)
9. Messing EM, Manola J, Yao J,. Immediate versus deferred androgen deprivation treatment in patients with node-positive prostate cancer after radical prostatectomy and pelvic lymphadenectomy. Lancet Oncol 2006; 7: 472-9 (Pubitemid 43779173)
10. Joslyn SA, Konety BR,. Impact of extent of lymphadenectomy on survival after radical prostatectomy for prostate cancer. Urology 2006; 68: 121-5 (Pubitemid 44037727)
11. Naselli A, Andreatta R, Introini C, Fontana V, Puppo P,. Predictors of symptomatic lymphocele after lymph node excision and radical prostatectomy. Urology 2010; 75: 630-5
12. Briganti A, Chun FK, Salonia A, et al,. Complications and other surgical outcomes associated with extended pelvic lymphadenectomy in men with localized prostate cancer. Eur Urol 2006; 50: 1006-13 (Pubitemid 44486500)
13. Solberg A, Angelsen A, Bergan U, Haugen OA, Viset T, Klepp O,. Frequency of lymphoceles after open and laparoscopic pelvic lymph node dissection in patients with prostate cancer. Scand J Urol Nephrol 2003; 37: 218-21 (Pubitemid 36791820)
14. Freid RM, Siegel D, Smith AD, Weiss GH,. Lymphoceles after laparoscopic pelvic node dissection. Urology 1998; 51: 131-4 (Pubitemid 28267889)
15. Musch M, Klevecka V, Roggenbuck U, Kroepfl D,. Complications of pelvic lymphadenectomy in 1,380 patients undergoing radical retropubic prostatectomy between 1993 and 2006. J Urol 2008; 179: 923-8
16. Zorn KC, Katz MH, Bernstein A, et al,. Pelvic lymphadenectomy during robot-assisted radical prostatectomy: assessing nodal yield, perioperative outcomes, and complications. Urology 2009; 74: 296-302
17. D'Amico AV, Whittington R, Malkowicz SB, et al,. Biochemical outcome after radical prostatectomy, external beam radiation therapy, or interstitial radiation therapy for clinically localized prostate cancer. JAMA 1998; 280: 969-74 (Pubitemid 28445094)
18. Orvieto MA, Patel VR,. Evolution of robot-assisted radical prostatectomy. Scand J Surg 2009; 98: 76-88
19. Tomic R, Granfors T, Sjödin JG, Ohberg L,. Lymph leakage after staging pelvic lymphadenectomy for prostatic carcinoma with and without heparin prophylaxis. Scand J Urol Nephrol 1994; 3: 273-5 (Pubitemid 24297348)
20. Coelho RF, Palmer KJ, Rocco B, et al,. Early complication rates in a single-surgeon series of 2500 robotic-assisted radical prostatectomies: report applying a standardized grading system. Eur Urol 2010; 57: 945-52
21. Scholz HS, Petru E, Benedicic C, Haas J, Tamussino K, Winter R,. Fibrin application for preventing lymphocysts after retroperitoneal lymphadenectomy in patients with gynecologic malignancies. Gynecol Oncol 2002; 84: 43-6 (Pubitemid 34056464)